HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White reiterates a Buy rating on InflaRx (NASDAQ:IFRX) and maintains a price target of $8.
June 24, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Edward White reiterates a Buy rating on InflaRx and maintains a price target of $8.
The reiteration of a Buy rating and the maintenance of a price target at $8 by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100